143 related articles for article (PubMed ID: 26408375)
1. Effect of oral contraceptives and doxycycline on endometrial MMP-2 and MMP-9 activity.
Kaneshiro B; Edelman A; Dash C; Pandhare J; Soli FM; Jensen JT
Contraception; 2016 Jan; 93(1):65-9. PubMed ID: 26408375
[TBL] [Abstract][Full Text] [Related]
2. Effects of doxycycline on serum and endometrial levels of MMP-2, MMP-9 and TIMP-1 in women using a levonorgestrel-releasing subcutaneous implant.
Zhao S; Choksuchat C; Zhao Y; Ballagh SA; Kovalevsky GA; Archer DF
Contraception; 2009 Jun; 79(6):469-78. PubMed ID: 19442784
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of subantimicrobial-dose doxycycline to prevent unscheduled bleeding with continuous oral contraceptive pill use.
Kaneshiro B; Edelman A; Carlson NE; Nichols M; Forbes MM; Jensen J
Contraception; 2012 Apr; 85(4):351-8. PubMed ID: 22067758
[TBL] [Abstract][Full Text] [Related]
4. Short term effects of doxycycline on matrix metalloproteinases 2 and 9.
Fiotti N; Altamura N; Moretti M; Wassermann S; Zacchigna S; Farra R; Dapas B; Consoloni L; Giacca M; Grassi G; Giansante C
Cardiovasc Drugs Ther; 2009 Apr; 23(2):153-9. PubMed ID: 19052856
[TBL] [Abstract][Full Text] [Related]
5. Combined oral contraceptives: risks and benefits.
Thorogood M; Villard-Mackintosh L
Br Med Bull; 1993 Jan; 49(1):124-39. PubMed ID: 8324603
[TBL] [Abstract][Full Text] [Related]
6. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding.
Galant C; Berlière M; Dubois D; Verougstraete JC; Charles A; Lemoine P; Kokorine I; Eeckhout Y; Courtoy PJ; Marbaix E
Am J Pathol; 2004 Jul; 165(1):83-94. PubMed ID: 15215164
[TBL] [Abstract][Full Text] [Related]
7. Treatment of unscheduled bleeding in continuous oral contraceptive users with doxycycline: a randomized controlled trial.
Kaneshiro B; Edelman A; Carlson N; Morgan K; Nichols M; Jensen J
Obstet Gynecol; 2010 Jun; 115(6):1141-1149. PubMed ID: 20502283
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors.
Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA
J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831
[TBL] [Abstract][Full Text] [Related]
9. Effect of warming Yang and removing blood stasis method on matrix metalloproteinases / tissue inhibitor metalloproteinases levels secreted by cultured endometrial cells from patients with endometriosis.
Huang Y; Shen L; Cai A; Xiao J
J Tradit Chin Med; 2015 Oct; 35(5):571-6. PubMed ID: 26591688
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression is not regulated by norgestimate or norelgestromin.
Prifti S; Lelle I; Zhong G; Strowitzki T; Rabe T
Gynecol Endocrinol; 2004 Jan; 18(1):23-7. PubMed ID: 15106361
[TBL] [Abstract][Full Text] [Related]
11. Doxycycline reduces MMP-2 activity and inhibits invasion of 12Z epithelial endometriotic cells as well as MMP-2 and -9 activity in primary endometriotic stromal cells in vitro.
Samartzis EP; Fink D; Stucki M; Imesch P
Reprod Biol Endocrinol; 2019 Apr; 17(1):38. PubMed ID: 30981279
[TBL] [Abstract][Full Text] [Related]
12. Doxycycline ameliorates ischemic and border-zone remodeling and endothelial dysfunction after myocardial infarction in rats.
Camp TM; Tyagi SC; Aru GM; Hayden MR; Mehta JL; Tyagi SC
J Heart Lung Transplant; 2004 Jun; 23(6):729-36. PubMed ID: 15366434
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases in the aneurysm wall of patients treated with low-dose doxycycline.
Ding R; McGuinness CL; Burnand KG; Sullivan E; Smith A
Vascular; 2005; 13(5):290-7. PubMed ID: 16288704
[TBL] [Abstract][Full Text] [Related]
14. Doxycycline impacts hernia repair outcomes.
Tharappel JC; Ramineni SK; Reynolds D; Puleo DA; Roth JS
J Surg Res; 2013 Sep; 184(1):699-704. PubMed ID: 23830364
[TBL] [Abstract][Full Text] [Related]
15. Association of Risk for Venous Thromboembolism With Use of Low-Dose Extended- and Continuous-Cycle Combined Oral Contraceptives: A Safety Study Using the Sentinel Distributed Database.
Li J; Panucci G; Moeny D; Liu W; Maro JC; Toh S; Huang TY
JAMA Intern Med; 2018 Nov; 178(11):1482-1488. PubMed ID: 30285041
[TBL] [Abstract][Full Text] [Related]
16. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells.
Liu J; Xiong W; Baca-Regen L; Nagase H; Baxter BT
J Vasc Surg; 2003 Dec; 38(6):1376-83. PubMed ID: 14681644
[TBL] [Abstract][Full Text] [Related]
18. Benefits and risks of oral contraceptives.
Drife J
Adv Contracept; 1990 Dec; 6 Suppl():15-25. PubMed ID: 2291444
[TBL] [Abstract][Full Text] [Related]
19. Metalloproteinases and tissue inhibitor of metalloproteinase 1 (TIMP-1) in endometrial flushings from pre- and post-menopausal women and from women with endometrial adenocarcinoma.
Laird SM; Dalton CF; Okon MA; Bunning RA; Marshall R; Li TC
J Reprod Fertil; 1999 Mar; 115(2):225-32. PubMed ID: 10434927
[TBL] [Abstract][Full Text] [Related]
20. Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.
Walker NF; Clark SO; Oni T; Andreu N; Tezera L; Singh S; Saraiva L; Pedersen B; Kelly DL; Tree JA; D'Armiento JM; Meintjes G; Mauri FA; Williams A; Wilkinson RJ; Friedland JS; Elkington PT
Am J Respir Crit Care Med; 2012 May; 185(9):989-97. PubMed ID: 22345579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
